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Abstract: Saccharomyces cerevisiae cells are killed by zymocin, a tRNase ribotoxin complex from
Kluyveromyces lactis, which cleaves anticodons and inhibits protein synthesis. Zymocin’s action
requires specific chemical modification of uridine bases in the anticodon wobble position (U34)
by the Elongator complex (Elp1-Elp6). Hence, loss of anticodon modification in mutants lacking
Elongator or related KTI (K. lactis Toxin Insensitive) genes protects against tRNA cleavage and confers
resistance to the toxin. Here, we show that zymocin can be used as a tool to genetically analyse
KTI12, a gene previously shown to code for an Elongator partner protein. From a kti12 mutant pool
of zymocin survivors, we identify motifs in Kti12 that are functionally directly coupled to Elongator
activity. In addition, shared requirement of U34 modifications for nonsense and missense tRNA
suppression (SUP4; SOE1) strongly suggests that Kti12 and Elongator cooperate to assure proper
tRNA functioning. We show that the Kti12 motifs are conserved in plant ortholog DRL1/ELO4 from
Arabidopsis thaliana and seem to be involved in binding of cofactors (e.g., nucleotides, calmodulin).
Elongator interaction defects triggered by mutations in these motifs correlate with phenotypes typical
for loss of U34 modification. Thus, tRNA modification by Elongator appears to require physical
contact with Kti12, and our preliminary data suggest that metabolic signals may affect proper
communication between them.
Keywords: zymocin; ribotoxin; tRNase; Kti12; Elongator complex; tRNA anticodon modification
1. Introduction
Zymocin, a composite chitinase and tRNA anticodon nuclease (tRNase) ribotoxin produced from
the dairy yeast Kluyveromyces lactis, kills other yeast species including Saccharomyces cerevisiae [1,2].
Although zymocin is a trimeric complex (αβγ), expression of its γ-subunit (i.e., γ-toxin tRNase) alone
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is lethal in S. cerevisiae, suggesting that the α/β-subunits facilitate zymocin docking and γ-toxin
delivery [2,3]. Accordingly, screens for zymocin survivors identified mutations in KTI (K. lactis toxin
insensitive) and IKI (insensitive to killer toxin) genes that fall into non-target (class I) and toxin-target
(class II) groups based on their response to conditional γ-toxin induction [3–5]. Class I genes operate in
the synthesis of cell wall and membrane components (chitin, sphingolipids, H+ pump Pma1) required
for zymocin binding and γ-toxin entry, and class II loci identified a toxin–target effector role for the
Elongator complex (Elp1–Elp6) [2,6]. Originally, the latter had been co-purified with elongating RNA
polymerase II, hence its name [7]. However, more recently a robust body of evidence indicates that its
genuine role in yeast lies with tRNA modification rather than transcription elongation. Accordingly,
Elongator binds tRNAs and modifies anticodon wobble uridine (U34) bases [8–14]. Strikingly, the
methoxy-carbonyl-methyl-thio (mcm5s2) modification at U34 in some of Elongator’s tRNA substrates
(including tRNAGlu) allows anticodon cleavage by the γ-toxin tRNase [15]. Therefore, loss of U34
modification in Elongator mutants protects efficiently against the toxin’s attack [6,15,16].
Elevated tRNAGlu levels also protect against zymocin, and this effect is suppressed by
overexpression of the class II gene KTI1/TRM9 [15,16]. Trm9 is the catalytic subunit of a
methyl-transferase (Trm9•Trm112), which methylates the preceding cm5(s2)U34 modification
generated by Elongator and also contributes to zymocin sensitivity [16–18]. Consistently, loss of
U34 methylation in trm9 and trm112 mutants confers resistance to zymocin and γ-toxin tRNase [18,19].
Thus, growth inhibition of S. cerevisiae by zymocin apparently involves restriction of U34-modified
tRNAs affecting protein biosynthesis. In support of this strategy, which is shared by other microbial
anticodon nucleases [20,21], zymocin depletes tRNAGlu in vivo, and overexpression of tRNA ligase
suppresses the tRNA attack showing that tRNA repair is able to ‘heal’ the damage in the anticodon
loop [22]. Use of the γ-toxin tRNase as a tool diagnostic for Elongator activity identified additional
class II gene products with related roles in tRNA modification [2,5,19,23–25]. Among them, a casein
kinase I isozyme (Hrr25/Kti14), a protein phosphatase (Sit4) and an Elongator partner protein
(Kti12) were found to constitute a complicated network that regulates the phosphorylation status
of Elongator’s largest subunit (Elp1) [26–28]. This suggested that phosphorylation affects Elongator
activity, a notion supported by data showing that Hrr25 phosphorylation sites on Elp1 are critical for
U34 modification [29] and that Hrr25 association with Elongator requires Kti12 [28].
Sequence alignments between Kti12 and its plant ortholog DRL1/ELO4 suggested that both
share a P-loop motif characteristic for nucleoside triphosphate (NTP) binders [30] and a putative
calmodulin (CaM) binding domain (CBD) [31]. With ELO4 known to bind CaM in vitro and associate
with plant Elongator in vivo [32,33], the presence of cofactor binding motifs points towards conserved
roles for Kti12 and ELO4. To further analyze Kti12 requirements for Elongator activity, we studied a
pool of zymocin resistant kti12 mutants previously used [5] to identify the KTI12 locus in yeast. We
map mutations in the CBD and P-loop motifs and other regions conserved between Kti12 and ELO4
that, based on genetic and biochemical assays, trigger traits typical of Elongator-linked loss of U34
modification and defects in Elongator interaction. In summary, our data reinforce the view that Kti12
relates in function to the yeast Elongator complex and stimulates its tRNA modification activity.
2. Results and Discussion
Based on its similarity to yeast Kti12, the Arabidopsis protein ELO4 was previously proposed
to play an Elongator-related role in plants [24,32]. This was confirmed when ELO4 was shown to
associate with TAP-tagged plant Elongator and ELO4 mutations found to cause phenotypes typical
of plant Elongator mutants [33]. In addition, alignments between Kti12 and ELO4 proteins from
fungal and plant species (Figure S1) revealed several regions of high similarity. Among these are
P-loop motifs, putative calmodulin (CaM) binding domains (CBDs) [24,31,32] and other homology
regions (Figure S1). While P-loops may be indicative of NTP binding [30], the CBDs likely mediate the
demonstrated in vitro binding of ELO4 to CaM [31,32]. In comparison to strong CBDs (type 1-5-10)
used, e.g., in tandem affinity purification (TAP) protocols [34], the CBDs in Kti12 or ELO4 (type 1-8-14)
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show weaker CaM affinity [35]. In summary, similarity in sequence and domain organisation may
indicate that the motifs found in Kti12 and ELO4 are evolutionarily conserved because they functionally
interact with Elongator.
2.1. A kti12 Mutant Pool Reveals Conserved Kti12 Motifs with Elongator-Related Roles
Given that KTI12 deletions cause Elongator defects [6,24,36], we analysed a previously isolated
pool of zymocin resistant kti12 mutants [5] in greater detail (Figure 1A). Single amino acid substitutions
within full-length Kti12 were mapped to the P-loop (kti12-4: S12R) and CBD1 (kti12-8: G92D) motifs
(Figure 1A). In addition, nonsense (kti12-1, kti12-2, kti12-3 and kti12-6) or frame-shift (kti12-5 and kti12-7)
mutations led to truncations resulting in deletion of various invariant Kti12 regions including one
or both CBD motifs (Figure 1A). Following assays diagnostic for Elongator-minus phenotypes, all
kti12 mutants were found to be zymocin resistant, hypersensitive to 7.5 mM caffeine (data not shown)
and sensitive to temperatures above 38 ◦C (Figure 1B). Collectively, these traits phenocopy kti12∆
and elp3∆ strains (Figure 1B), reinforcing the view that Kti12 and Elongator are closely related in
function [6,24,36].
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Elongator mutant (elp3∆) include zymocin resistance (R) and thermosensitivity (+); zymocin 
sensitivity (S) and thermotolerance (−) denote wild-type (KTI12) phenotypes; (C) phase contrast 
microscopy to monitor cell/bud morphology in the indicated strain backgrounds. 
In addition, significant proportions of kti12∆ (11%), kti12-4 (14%) and elp1∆ (14%) mutants 
showed aberrantly elongated cells/buds (Figure 1C), morphological defects previously observed in 
association with Elongator or related tRNA modification mutants including kti14/hrr25 cells 
[25,28,37]. Consistent with Elongator mutations known to suppress thermosensitive growth of sec2-
59ts and sec12-4ts mutants at 31 °C and 33 °C, respectively [38,39], sec mutant rescue was also seen with 
Figure 1. A set of kti12 mutants uncovers a phenotypic signature typical of Elongator defects.
(A) compilation of kti12 mutants including mutation mapping and alignment t Kti12 domain
organization (for details, see Figure S1); (B,C) phenotypes shared between kti12 and Elongator
mutants. Growth assays (B) with yeast strains of the indicated backgrounds at 30 ◦C (control), elevated
temperature (38 ◦C) or in the presence of 45% [v/v] zymocin (+zymo). Traits typical of Elongator
mutant (elp3∆) include zymo in resistance (R) and thermosensitivity (+); zymocin sensitivity (S) and
thermotolerance (−) denote wild-type (KTI12) phenotypes; (C) phase contrast microscopy to monitor
cell/bud morphology in the indicated strain backgrounds.
In addition, significant proportions of kti12∆ (11%), kti12-4 (14%) and elp1∆ (14%) mutants showed
aberrantly elongated cells/buds (Figure 1C), morphological defects previously observed in association
with Elongator or related tRNA modification mutants including kti14/hrr25 cells [25,28,37]. Consistent
with Elongator mutations known to suppress thermosensitive growth of sec2-59ts and sec12-4ts mutants
at 31 ◦C and 33 ◦C, respectively [38,39], sec mutant rescue was also seen with the kti12-4 and kti12-8
alleles (Figure S2), although to a lesser extent than elp1∆. In summary, an Elongator-like phenotypic
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signature of KTI12 loss-of-function alleles documents the usefulness of zymocin as a tool diagnostic
for Kti12 protein motifs that are important for Elongator activity.
2.2. Conserved Kti12 Motifs Support Elongator-Dependent tRNA Suppression
Physiologically, Elongator-dependent tRNA modification fine-tunes tRNA decoding [40–43] and
maintains ribosomal reading frame accuracy during translation [44–47]. In support, stop codon
read-through by U34 carrying tRNA suppressors (SUP4; sup9e) requires Elongator function [8,16,39].
Inspired by previous data showing that some class II kti mutants also have tRNA modification
defects [8,19], we compared SUP4 read-through between members of the kti12 mutant collection
and an elp3∆ knock-out in reporter strain UMY2893. The latter maintains ochre (UAA) alleles of
ADE2 (ade2-1) and CAN1 (can1-100), which upon suppression by SUP4, confer adenine prototrophy
(Ade+) and canavanine sensitivity (CanS), respectively [8,16]. In agreement with previous reports,
SUP4 read-through of ade2-1 and can1-100 was abolished by ELP3 gene deletion yielding adenine
auxotrophic (Ade−) and canavanine resistant (CanR) elp3∆ cells (Figure 2A). Notably, both traits (Ade−,
CanR) were copied by all the kti12 mutant alleles (kti12-1, kti12-3, kti12-4, kti12-6, kti12-7 and kti12-8)
we tested (Figure 2A) and complemented after reintroducing a KTI12 wild-type gene into kti12∆ cells
(Figure 2A). The latter finding supports our notion that recessive KTI12 loss-of-function alleles trigger
Elongator-linked tRNA modification defects and phenotypes in yeast (Figures 1 and 2).
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Figure 2. KTI12 gene mutations and copy number interfere with U34 tRNA suppressors. (A) tRNA
nonsense suppression. In the indicated genetic backgrounds, can1-100 and ade2-1 ochre read-through
by SUP4 was phenotypically assessed by canava ine sensitivity/resistance (S R: middle panel) on
canavanine su pl mented edium lack ng arginine (+can −arg) or by adenine proto-/auxotrophy
(+/−: bottom panel) on minimal medium without adenine (−ade). Growth control (top panel) involved
yeast peptone dextrose (YPD) rich medium. Empty vector (ev) served as reference for multi-copy
(mc) KTI12; (B) SOE1 tRNA missense suppression. The indicated strains were grown at temperatures
permissive (30 ◦C) or restrictive (36 ◦C) for cdc8-1ts cells. Note that ELP1 and KTI12 gene mutations
affect (+) re cu of cdc8-1ts cell growth at 36 ◦C (−) by the tRNA suppr ssor SOE1.
Consistent with our previous observation that Elongator dependent processes (including e.g.,
zymocicity) can be suppressed by overexpression of KTI12 [5,26], multi-copy KTI12 also countered
tRNA suppression of can1-100 by SUP4 (Figure 2A). As for ade2-1, however, ulti-copy KTI12, allowed
weak growth in m dium lack g adenine, a tr it in between the ph notypes of wild-type ( de+) or
elp3/kti12 mutant (Ade−) cells (Figure 2A). The latter read-out may indicate that the two ochre reporters
differ in their level of sensitivity level to Elongator defects. Presumably, a weaker Ade+ trait could
be interpreted in a way that increased intracellular Kti12 levels also decrease the tRNA modification
activity of Elongator (Figure 2A). It will be interesting to address this scenario in greater detail in future
studies using quantitative lacZochre read-through assay or direct LC-MS/MS measurements [29,48,49].
These techniques will allow comparison of the relative abundance of Elongator dependent U34
modification levels between mutants lacking Kti12 and cells expressing Kti12 at elevated levels from
either single-copy or multi-copy plasmids.
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In addition, we observed that similar to kti12∆ and elp1∆ cells, kti12-4 and kti12-8 alleles also
antagonized tRNA missense suppression of cdc8-1ts by SOE1 (Figure 2B), a mutant tRNAGlu that reads
Lys codons in a fashion dependent on U34 modification by Elongator [39,50]. Hence, proper Elongator
and Kti12 activity are required for SOE1 to rectify Glu to Lys substitutions in cdc8-1ts cells and thus
suppress their thermosensitivity at 36 ◦C (Figure 2B). Together with previous data showing that
missense (SOE1) and nonsense (SUP4; sup9e) suppressor tRNAs depend on Elongator [8,16,39], Kti12 can
thus be considered to promote suppressor tRNA functionality, most likely through its regulatory role
in Elongator’s tRNA modification reaction.
2.3. Kti12 Expression and Interaction Profiles
To examine whether and how the mutated Kti12 proteins are expressed, we subjected kti12-2,
kti12-3, kti12-4 and kti12-8 alleles to genomic c-Myc-tagging. Following Western blot analyses,
all epitope-tagged Kti12 variants were found to be produced at the expected molecular weights
(Figure 3A); Kti12-4 and Kti12-8 are full-length (~40 kDa) while Kti12-2 (~26 kDa) and Kti12-3
(~35 kDa) represent C-terminal truncations (Figure 3A). In addition, while Kti12-3 and Kti12-4 levels
were reduced, Kti12-2 and Kti12-8 expression compared favourably with Kti12 wild-type levels
(Figure 3A). To avoid abundance related secondary effects, we conducted subsequent analyses with
the latter two mutants. Since Kti12 and Elongator associate with each other [6,24,28,36], we examined
whether inappropriate interaction between both may underlie the loss-of-function traits observed
in kti12-2 and kti12-8 cells (Figures 1 and 2). Therefore, c-Myc-tagged KTI12, kti12-2 and kti12-8
alleles (Figure 3A) were each co-expressed with an HA-tagged copy of the ELP2 gene for co-immune
precipitation (IP) assays (Figure 3B). Unlike the strong interaction observed between wild-type Kti12
and Elp2 (Figure 3B), the Elongator subunit failed to co-precipitate Kti12-2 and Kti12-8 (Figure 3B)
and both mutants hardly co-purified Elp2 in reciprocal IPs (data not shown). This indicates that a
proper interaction with Elongator requires both the structural integrity of CBD2 and conserved Kti12
residues further downstream (truncated in kti12-2 cells) and an intact CBD1 motif (mutated in kti12-8
cells) (Figure 1A). Whether the G92D mutation (Figure 1A) affects Elongator interaction in kti12-8
cells through changes in local hydrophobicity (Figure S4) is an option currently under investigation.
In summary, loss of Elongator binding due to mutations in specific and putative functional Kti12
domains correlates with Elongator-minus traits (Figures 1 and 2). These observations again support
our previously presented working hypothesis that direct physical contact with Kti12 is required for
Elongator’s ability to modify tRNA anticodons [6,28,29].
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Figure 3. Kti12 expression and Elongator interaction studies. (A) expression of Kti12 and its mutated
variants. The in icated KTI12/kti12 alleles were genomically c-Myc-tagged and each gene product
identified (top panel) in anti-c-Myc Western blots of total yeast protein extracts. An i ependent,
anti-Cdc19 blot served as internal control (bottom panel); (B) elongator interaction studies with Kti12
and its mutants. Strains co-expressing Elp2-HA and c-Myc-tagged Kti12, Kti12-2 or Kti12-8 were
subjected to anti-HA immune precipitation (IP). The IPs were probed for Elp2-HA (top panel) or
Kti12-c-Myc (middle panel) with anti-HA or anti-c-Myc antibodies, respectively. Total protein extracts
(preIP, bottom panel) probed with anti c-Myc antibodies served as Kti12 input control.
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2.4. Affinity of Kti12 for CaM
As the putative CBDs may be involved in Kti12 function (Figures 2 and 3) [24,31,32], we examined
next whether yeast Kti12 binds to CaM. In detail, we subjected total yeast extracts containing
c-Myc-tagged Kti12 or Kti12-8 to CaM Sepharose affinity chromatography. Extracts containing
Kti13-c-Myc, a protein without any CBD motif, or Kti12-TAP with a high-affinity CaM-tag were
used as negative and positive controls, respectively (Figure 4). Protein bound to the CaM matrix was
eluted with EGTA to chelate calcium and analyzed in Western blots. Both wild-type Kti12-c-Myc and
Kti12-8-c-Myc could be detected in the eluate, whereas the negative control Kti13-c-Myc could not
(Figure 4). The flow-through fractions indicate that, as expected, the affinity of Kti12-c-Myc is lower
than that of Kti12-TAP, which carries an additional CBD derived from the TAP tag [34]. Whether
the second CBD (Figure S1) might contribute to residual binding of the kti12-8 mutant to CaM is not
known. Collectively, our data indicate that Kti12 and Kti12-8 bind CaM in a calcium sensitive manner.
Although they cannot unambiguously provide evidence that the Gly-92 residue in Kti12 is part of a
bona fide CBD, they show that Kti12 has CaM affinity, a finding consistent with demonstrated in vitro
binding of plant ELO4 to CaM [32]. Whether the ability of Kti12 to bind CaM contributes to Elongator
function has to await further investigation.
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washes) and eluted (EGTA elution) protein fractions were subjected to anti-TAP (top panel) and anti
c-Myc Western blots (other panels); (B) killer eclipse assays between the same S. cerevisiae strains used
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2.5. Cross-Complementation Analysis between KTI12 and ELO4
Based on several lines of evidence including sequence similarities (27.9% identity; 45.3% similarity,
Figure S1), elongator-related functions in vivo and CaM binding in vitro (Figure 4) [31–33], Kti12 and
ELO4 may be functional counterparts. To study structure and functional conservation between
subdomains (Figure 5A), we engineered hybrid alleles of KTI12 encoding motif-swapped proteins in
which the P-loop or CBD1 motif from Kti12 is replaced with the respective ELO4 seque ce (Figure 5B).
After introducing these into a kti12∆ reporter strain, both hybrids were able to complement the loss-of
function ph notyp of the mu ant; se sitivity to growth inh bition by the γ-tox tRNase subunit
of zymocin (Figure 5C) and ochre codon read-through of ade2-1 by SUP4 (Figure 5D) were restored.
In contrast, the plant ELO4 gene leaves γ-toxin resistance and adenine auxotrophy (Ade−) of kti12∆
cells unchanged (Figure 5C,D). Hence, the Arabidopsis homologue of Kti12 is unable to replace Kti12
function in yeast, whereas the hybrid proteins are functional. We conclude that sequence differences in
the highly conserved motifs are unlikely to be responsible for the specificity of Kti12. Notably, the KTI12
gene from K. lactis, which is more closely related to that of S. cerevisiae, is also unable to complement
the kti12∆ mutation (data not shown). To address the question of whether Elongator interactions are
retained in the motif-swapped Kti12-c-Myc variants, they were co-expressed with Elp1-HA, and IPs
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were performed with anti-HA antibodies. Elp1-HA co-precipitated native Kti12 and both hybrids
(Figure 5E). Based on protein expression in the extracts prior to IP that were compared to wild-type
Kti12 levels, the CBD1-swapped hybrid may be slightly reduced in Elp1 interaction. In summary, we
conclude that while alleles coding for hybrids, in which conserved cofactor binding motifs of ELO4
(P-loop, CBD1) have been engineered into yeast Kti12, are functionally exchangeable, full-length plant
ELO4 is not. Cross-complementation was also absent with plant ELO4 homologs from rice (OsELO4)
and moss (PpELO4) (Figure S3). The incompatibility of ELO4 with Elongator function in S. cerevisiae
contrasts with previous findings showing that elp1∆mutants can be partially rescued by ELO2, the plant
homolog of yeast ELP1 [51]. Strikingly, the most highly conserved Elongator subunit gene (ELP3) gene
cannot be replaced in yeast by the Arabidopsis ELP3 homolog even though the plant subunit assembled
into holo-Elongator complexes [9]. However, functional complementation in yeast was achieved
when the two plant Elongator genes (ELO2, ELP3) were co-expressed in the genetic background of an
elp1∆ elp3∆ double mutant [9]. Hence, non-conserved plant-specific sequences in ELO4 may mediate
a selective physical or functional interaction with individual Elongator subunits, Hrr24 or Sit4 to
explain the failure of cross-complementation in our gene shuffle experiments (Figure 5C,D). Regions
of species-specific sequence variation may thus provide first insights into the evolutionary differences
between plant ELO4 and yeast Kti12.
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complementation was studied by (C) conditional γ-toxin tRNase expression [6] on glucose (γ-toxin: 
off) vs. galactose (γ-tox: on) and (D) SUP4 nonsense suppression of ade2-1 (see also Figure 2A). R/S: γ-
Figure 5. KTI12 and ELO4 gene shuffle analysis. (A) A PSTK homolog-based structural model of
yeast Kti12 with highlighted c nserved P-lo p (blue) and CBD1 (pink) in cart on representation.
PSTK based structures of P-loop (PL) and CBD1 from ELO4 provide a structural insight into the
motif swap experiment. Highly conserved residues are shown in ball and stick representation,
and labelled respectively; (B) Indication of PL and CBD motif shuffling from ELO4 to Kti12;
(C,D) cross-complementation was studied by (C) conditional γ-toxin tRNase expression [6] on glucose
(γ-toxin: off) vs. galactose (γ-tox: on) and (D) SUP4 nonsense suppression of ade2-1 (see also Figure 2A).
R/S: γ-toxin resistance/sensitivity; +/−: adenine proto-/auxotrophy; (E) elongator interaction. Strains
co-expressing Elp1-HA and indicated c-Myc-tagged Kti12 variants were subjected to anti-HA immune
precipitation (IP). The IPs were probed with anti-HA and anti-c-Myc antibodies to check for content of
Elp1-HA (top panel) and co-precipitated Kti12 material (middle panel). Total extracts (bottom panel)
were probed with anti-c-Myc antibodies and served as input (preIP) control.
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3. Conclusions
To conclude, the zymocin tRNase ribotoxin can be exploited as a molecular diagnostic tool to
assign function to motifs conserved in two Elongator partner proteins, Kti12 and plant ELO4. These
motifs are potentially involved in cofactor binding (nucleotide, calmodulin) and when mutated,
abolish Elongator interaction and trigger phenotypes typical of tRNA modification defects in known
Elongator mutants. Thus, tRNA modification by Elongator appears to require physical contact
and proper communication with Kti12, a notion further supported by our findings that Kti12 and
Elongator cooperate in proper performance of nonsense and missense tRNA suppressors (SUP4, SOE1).
Despite their structural and functional similarities, Kti12 and ELO4 cannot be functionally exchanged
between yeast and plant cells. This suggests the occurrence of species-specific barriers or evolutionary
diversification of Elongator and its associated regulatory proteins between lower and higher eukaryotes.
In summary, we provide further evidence for a dynamic and complicated network underlying potential
regulation of the U34 modification pathway. It constitutes regulatory proteins including Kti11/Dph3,
Kti12, Kti13/Ats1 and Kti14/Hrr25 [28,29,36,39,52–55] whose associations with the Elongator complex
appear to be sensitive to certain metabolic signals. In support of this notion are recent findings showing
that loss of U34 modifications cause altered metabolic profiles in Elongator mutants [56].
4. Materials and Methods
4.1. Yeast Strains, Media and General Methods and Plasmid Constructions
Growth of yeast strains (Table S1) was in routine YPD or SC media [57] for 3 days at 30 ◦C.
Thermosensitivity was assessed by cultivation at elevated (31 ◦C, 33 ◦C, 36 ◦C, 39 ◦C) temperatures.
Caffeine sensitivity involved YPD supplementation with 7.5 mM of the chemical (Sigma Aldrich,
Taufkirchen, Germany). Table S2 lists primers used for PCR-based protocols to epitope tag and
delete genes and to map kti12 mutations [3,5] by Sanger DNA sequencing. Transformation of yeast
cells with PCR products and plasmids (Table S3) was done as described [58]. Monitoring zymocin
sensitivity/resistance used direct colony-colony eclipse assays [4] between K. lactis killer strain AWJ137
(Table S1) and S. cerevisiae tester strains or YPD plate assays containing 40–50% (v/v) partially purified
zymocin [26]. Responses towards intracellular expression of zymocin’s lethal tRNase subunit (γ-toxin)
used GAL1-γ-toxin expression vector pHMS14 as described [6]. ade2-1 and can1-100 ochre read-through
by SUP4 and missense suppression of cdc8-1ts by SOE1 followed previous protocols [8,16,50] as did
sec2-59ts and sec12-4ts suppression assays [38,39]. Construction details of KTI12 hybrid alleles, in which
the P-loop and CBD domains were replaced with ELO4 motifs (PLELO4 & CBDELO4; Figure 5B) by
two-step fusion PCR, template plasmid pDJ75 and indicated primers (Table S2), can be made available
on request. Expression of ELO4/DRL1 cDNAs from Arabidopsis (AtELO4), rice (PpELO4) and moss
(PpELO4) under control of the TDH3 promoter utilized single-copy vector pTU1 [31]. For functional
analysis, kti12 mutant and KTI12 wild-type alleles were moved following rescue (see below) from the
multi-copy backbone of pJHW27 into single-copy vector YCplac33 [59].
4.2. Functional Analysis of the kti12 Mutant Pool and Genomic Manipulations at the ELP and KTI Loci
To identify individual KTI12 mutations from the kti12 pool (kti12-1 to kti12-8) (Table S1), ARB(K)
member strains [3,5] raised in LL20 and KY117 backgrounds (Table S1) were subjected to gap repair
in vivo using plasmids pJHW27 or pDJ40 (Table S3) restricted with NdeI and NcoI [5] or to direct kti12
locus amplification. The latter used genomic DNA for PCR with Pfu polymerase (Fermentas) and
primers KTI12-P and KTI12-4 (Table S2). Yeast plasmids rescued in E. coli or generated by sub-cloning
the above PCR products in TOPO pCR2.1 (Invitrogen, Thermo-Fisher Scientific, Waltham, MA, USA)
were sequenced in reactions containing 4 µL of ready reaction premix (2.5×), 2 µL of BigDye terminator
v1.1 sequencing buffer (5×) (Applied Biosystems, Waltham, MA, USA), 200–500 ng of plasmid DNA
and 3.2 pmol of sequencing primers KTI12-P and KTI12-1 to KTI12-4 (Table S2) in a final volume
of 20 µL. Following 30 cycles, the PCR reactions were subjected to ethanol precipitations and run
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on an ABI-Prism 377 DNA sequencer (PerkinElmer, Hamburg, Germany). Tagging of KTI12 alleles
and Elongator subunit genes (ELP1, ELP2) with c-Myc or HA epitopes essentially followed previous
PCR protocols [6,24] using the S2/S3 primer pairs (Table S2) compatible with the pYM template
plasmids (Table S3). KTI12-TAP involved the PCR protocol of Puig et al. [34] with template plasmid
pBS1479 (Table S3) and up/down-KTI12primers (Table S2). c-Myc tagging of KTI13 was previously
described [23]. KTI12, ELP1 and ELP2 gene deletions were created using published [6,24] PCR protocols,
primers and marker plasmids (Tables S2 and S3). Gene deletions were physically verified by PCR
on genomic DNA preparations using gene-specific diagnostic primers (Table S2) and phenotypically
confirmed by zymocin assays (see above).
4.3. KTI12 Expression Analyses and Elongator or CaM Interaction Studies
Immune detection of epitope-tagged Kti12 and Elongator subunits and immune precipitations
(IPs) from total yeast extracts used anti-c-Myc (9E10) and anti-HA (3F10) antibodies (Roche) as
previously described [6,24]. Protein loading was checked with anti-Cdc19 serum (a kind donation by
Dr J. Thorner, University of California, Berkley, CA, USA), which recognizes pyruvate kinase. CaM
binding assays in vitro involved TAP-tagged or c-Myc-marked Kti12 and Kti13 proteins from total
yeast extracts (~2 mg) adjusted to 1 mM CaCl2. The material (2 mL) was mixed with CaM-Sepharose
for 30 min and equilibrated with 2 mL CaM binding buffer (CBB) as described [32]. The slurry was
packed onto a column, the buffer drained, and the column rinsed twice with 2.5 volumes of CBB.
Elution of bound proteins was in EGTA buffer (4 mM Tris-HCl, pH 7.5, 200 mM NaCl, 1 mM MgCl2,
2 mM EGTA, and 0.1 mM DTT). Equal proportions of load, flow-through, wash, and elution fractions
were separated by 15% SDS-PAGE, and Kti12 material was detected using anti-TAP and anti-c-Myc
Western blots.
4.4. Kti12 Secondary Structure Predictions and Alignments with ELO4/DRL1
Secondary structure predictions for Kti12 and ELO4 proteins were obtained using the
semi-automated homolog-based protein fold recognition server Phyre2.0 [60]. Best matching records,
in both cases based on the crystal structure of archaeal O-phosphoseryl-tRNA(Sec) kinase (PSTK, PDB:
3A4M) [61], were further used to visualize Kti12 domain architecture and illustrate a motif-swap
experiment (Figure 5B). All structures were rendered using PyMOL Molecular Graphics System
(http://www.pymol.org/) (Version 1.8 Schrödinger, LLC, New York, NY, USA). Sequences of Kti12 or
its homologs from indicated organisms were obtained from NCBI. Multiple alignments were generated
using MUSCLE available at EMBL-EBI web page (http://www.ebi.ac.uk/Tools/msa/muscle/). MSA
files were handled using JalView software [62]. Homolog-based model and multiple alignment were
used for sequence conservation illustration with the CONSURF server (http://consurf.tau.ac.il/) [63].
Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/9/9/272/s1,
Figure S1: Multiple Kti12 sequence alignment; Figure S2: ELP1 and KTI12 mutations rescue thermosensitivity of
sec2-59ts and sec12-4ts mutants; Figure S3: Analysis of yeast kti12 cross-complementation by ELO4 plant homologs;
Figure S4: Hydropathy plots of Val-82 to Lys-102 spanning regions in Kti12 and Kti12-8; Table S1: Yeast strains;
Table S2: Primers; Table S3: Plasmids.
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